Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability

By Nielsen O. W.   Rasmussen V.   Christensen N. J.   Hansen J. F.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 64, Iss. 7, 2004-10 ,pp. : 619-628

Informa Healthcare

Access to resources Recommend Favorite

Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age

By Holmström H.   Hall C.   Stokke O.   Thaulow E.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 60, Iss. 2, 2000-04 ,pp. : 149-159

Informa Healthcare

Access to resources Recommend Favorite

Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary Symptoms

By  

Oncology, Vol. 90, Iss. 3, 2016-02 ,pp. : 143-150

Karger

Access to resources Recommend Favorite

Increased serum level of N‐terminal Pro‐B‐type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 1010-1014

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ghrelin and Its Relation with N-Terminal Brain Natriuretic Peptide, Endothelin-1 and Nitric Oxide in Patients with Idiopathic Pulmonary Hypertension

By  

Cardiology, Vol. 124, Iss. 4, 2013-04 ,pp. : 241-245

Karger

Access to resources Recommend Favorite